Senegal’s $7.1m sickle cell drug push targets six African markets

Senegal is pursuing a $7.1 million initiative to expand access to a sickle cell drug across six African markets. The effort signals a regional push to address sickle cell disease through wider availability of treatment, although the headline does not specify the targeted countries, funding structure or implementation timeline.